Skip to main content
Journal cover image

Current results of a phase I study of DKN-01 in combination with paclitaxel (P) in patients (pts) with advanced DKK1+esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ)

Publication ,  Conference
Ryan, DP; Murphy, J; Mahalingam, D; Strickler, J; Stein, S; Sirard, C; Landau, S; Bendell, J
Published in: ANNALS OF ONCOLOGY
June 1, 2016

Duke Scholars

Published In

ANNALS OF ONCOLOGY

EISSN

1569-8041

ISSN

0923-7534

Publication Date

June 1, 2016

Volume

27

Start / End Page

108 / 108

Location

Barcelona, SPAIN

Publisher

OXFORD UNIV PRESS

Conference Name

18th World Congress of the European-Society-for-Medical-Oncology (ESMO) on Gastrointestinal Cancer

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ryan, D. P., Murphy, J., Mahalingam, D., Strickler, J., Stein, S., Sirard, C., … Bendell, J. (2016). Current results of a phase I study of DKN-01 in combination with paclitaxel (P) in patients (pts) with advanced DKK1+esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ). In ANNALS OF ONCOLOGY (Vol. 27, pp. 108–108). Barcelona, SPAIN: OXFORD UNIV PRESS.
Ryan, D. P., J. Murphy, D. Mahalingam, J. Strickler, S. Stein, C. Sirard, S. Landau, and J. Bendell. “Current results of a phase I study of DKN-01 in combination with paclitaxel (P) in patients (pts) with advanced DKK1+esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ).” In ANNALS OF ONCOLOGY, 27:108–108. OXFORD UNIV PRESS, 2016.
Ryan DP, Murphy J, Mahalingam D, Strickler J, Stein S, Sirard C, et al. Current results of a phase I study of DKN-01 in combination with paclitaxel (P) in patients (pts) with advanced DKK1+esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ). In: ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2016. p. 108–108.
Ryan DP, Murphy J, Mahalingam D, Strickler J, Stein S, Sirard C, Landau S, Bendell J. Current results of a phase I study of DKN-01 in combination with paclitaxel (P) in patients (pts) with advanced DKK1+esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ). ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2016. p. 108–108.
Journal cover image

Published In

ANNALS OF ONCOLOGY

EISSN

1569-8041

ISSN

0923-7534

Publication Date

June 1, 2016

Volume

27

Start / End Page

108 / 108

Location

Barcelona, SPAIN

Publisher

OXFORD UNIV PRESS

Conference Name

18th World Congress of the European-Society-for-Medical-Oncology (ESMO) on Gastrointestinal Cancer

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis